2019
DOI: 10.1177/0003319719862681
|View full text |Cite
|
Sign up to set email alerts
|

Complementary Impact of Carotid Intima–Media Thickness With Plaque in Associations With Noncardiac Arterial Vascular Events

Abstract: The ability of carotid intima–media thickness (IMT) to predict risk beyond plaque is controversial. In 952 participants (critical limb ischemia [CLI] or stroke, n = 473; community, n = 479), we assessed whether relationships with events for IMT complement the impact of plaque in young patients depending on the extent of thrombotic versus atherosclerotic disease. The extent of atherosclerotic versus thrombotic occlusion was determined in 54 patients with CLI requiring amputations. Thrombotic occlusion in CLI wa… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
8
0

Year Published

2019
2019
2021
2021

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(8 citation statements)
references
References 27 publications
0
8
0
Order By: Relevance
“…A common error (noted in the study by Kolkenbeck-Ruh et al 1 and others 20 ) is the comparison of the presence or absence of carotid plaque (a categorical variable) with the quantity of IMT as a continuous variable. Continuous variables are about 3 times more powerful for statistical purposes than categorical variables.…”
Section: Carotid Total Plaque Areamentioning
confidence: 99%
See 4 more Smart Citations
“…A common error (noted in the study by Kolkenbeck-Ruh et al 1 and others 20 ) is the comparison of the presence or absence of carotid plaque (a categorical variable) with the quantity of IMT as a continuous variable. Continuous variables are about 3 times more powerful for statistical purposes than categorical variables.…”
Section: Carotid Total Plaque Areamentioning
confidence: 99%
“…The conclusion reached was that cIMT complements the performance of carotid plaque presence for CV event detection in younger, but not older, patients. 1 Since the development and validation of the measurement of cIMT in the 1980s, 2,3 many reports have relied on this imaging marker as a surrogate for atherosclerosis in studies of risk factors, genetics/epigenetics, and evaluation of therapies including lipid-lowering drugs. 4 It is a widespread misconception that increased cIMT represents "preclinical atherosclerosis."…”
mentioning
confidence: 99%
See 3 more Smart Citations